GNOM Insider Trading Activity and SEC Form 4 Filings
GNOM insider trading summary
No open-market insider purchases or sales of Complete Genomics Inc (GNOM) have been reported on SEC Form 4 in the past 12 months.
Latest GNOM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 13, 2012 | OrbiMed Capital GP III LLC | 10% Owner | Sell | $1.2M (474,800 @ $2.51) |
| Jul 13, 2012 | Samuel D Isaly | 10% Owner | Sell | $1.2M (474,800 @ $2.51) |
| Jul 13, 2012 | OrbiMed Capital GP III LLC | 10% Owner | Sell | $11K (4,500 @ $2.51) |
| Jul 13, 2012 | Samuel D Isaly | 10% Owner | Sell | $11K (4,500 @ $2.51) |
| Jul 13, 2012 | Orbimed Advisors LLC | 10% Owner | Sell | $11K (4,500 @ $2.51) |
| Jul 13, 2012 | Orbimed Advisors LLC | 10% Owner | Sell | $1.2M (474,800 @ $2.51) |
| Jul 12, 2012 | Samuel D Isaly | 10% Owner | Sell | $623K (218,624 @ $2.85) |
| Jul 12, 2012 | Samuel D Isaly | 10% Owner | Sell | $6K (2,076 @ $2.85) |
| Jul 12, 2012 | OrbiMed Capital GP III LLC | 10% Owner | Sell | $6K (2,076 @ $2.85) |
| Jul 12, 2012 | Orbimed Advisors LLC | 10% Owner | Sell | $6K (2,076 @ $2.85) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.